Antibody-drug conjugates (ADCs) represent a rapidly evolving class of potent biopharmaceuticals, combining the selective targeting of monoclonal antibodies with the cytotoxic power of small-molecule drugs. These targeted cancer therapies are reliant on cleavab... ...

请注册登录后继续浏览